BE899278A - Agent antimycotique a haute liberation de substance active sous forme d'une creme. - Google Patents
Agent antimycotique a haute liberation de substance active sous forme d'une creme.Info
- Publication number
- BE899278A BE899278A BE0/212659A BE212653A BE899278A BE 899278 A BE899278 A BE 899278A BE 0/212659 A BE0/212659 A BE 0/212659A BE 212653 A BE212653 A BE 212653A BE 899278 A BE899278 A BE 899278A
- Authority
- BE
- Belgium
- Prior art keywords
- active substance
- cream
- release
- antimycotic agent
- agent
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 2
- 239000003429 antifungal agent Substances 0.000 title 1
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 abstract 1
- 230000001857 anti-mycotic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833311701 DE3311701A1 (de) | 1983-03-30 | 1983-03-30 | Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE899278A true BE899278A (fr) | 1984-10-01 |
Family
ID=6195162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/212659A BE899278A (fr) | 1983-03-30 | 1984-03-29 | Agent antimycotique a haute liberation de substance active sous forme d'une creme. |
Country Status (19)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5087620A (en) * | 1990-05-17 | 1992-02-11 | Bristol-Myers Squibb Co. | Controlled dermal penetration enhancement using imidazoles |
| AU4399793A (en) * | 1992-06-08 | 1994-01-04 | Schering-Plough Healthcare Products, Inc. | Stable imidazole anti-fungal powder compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2461406C2 (de) * | 1974-12-24 | 1984-06-14 | Bayer Ag, 5090 Leverkusen | Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| DE3045914A1 (de) * | 1980-12-05 | 1982-07-22 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern |
| DE3045915A1 (de) * | 1980-12-05 | 1982-07-08 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern |
| DE3045913A1 (de) * | 1980-12-05 | 1982-07-08 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel mit hoher wirkstoff-freisetzung |
| DE3106635A1 (de) * | 1981-02-23 | 1982-09-09 | Bayer Ag | Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften |
-
1983
- 1983-03-30 DE DE19833311701 patent/DE3311701A1/de not_active Withdrawn
-
1984
- 1984-03-22 ES ES530846A patent/ES530846A0/es active Granted
- 1984-03-26 PT PT78313A patent/PT78313B/pt unknown
- 1984-03-26 JP JP59056374A patent/JPS59184106A/ja active Pending
- 1984-03-27 PH PH30446A patent/PH20420A/en unknown
- 1984-03-28 LU LU85271A patent/LU85271A1/de unknown
- 1984-03-28 GR GR74236A patent/GR81485B/el unknown
- 1984-03-28 CA CA000450707A patent/CA1212327A/en not_active Expired
- 1984-03-29 FR FR8404906A patent/FR2543435B1/fr not_active Expired
- 1984-03-29 SE SE8401748A patent/SE8401748L/xx unknown
- 1984-03-29 BE BE0/212659A patent/BE899278A/fr not_active IP Right Cessation
- 1984-03-29 CY CY135884A patent/CY1358A/en unknown
- 1984-03-29 ZA ZA842337A patent/ZA842337B/xx unknown
- 1984-03-29 GB GB08408067A patent/GB2137091B/en not_active Expired
- 1984-03-29 CH CH1598/84A patent/CH660126A5/de not_active IP Right Cessation
- 1984-03-29 AU AU26236/84A patent/AU564956B2/en not_active Expired
- 1984-03-29 IT IT20303/84A patent/IT1173761B/it active
- 1984-03-30 KR KR1019840001659A patent/KR840008284A/ko not_active Ceased
- 1984-12-31 ES ES539289A patent/ES539289A0/es active Granted
- 1984-12-31 ES ES539290A patent/ES8601693A1/es not_active Expired
-
1987
- 1987-03-09 KE KE3704A patent/KE3704A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT8420303A0 (it) | 1984-03-29 |
| ES8503947A1 (es) | 1985-04-16 |
| JPS59184106A (ja) | 1984-10-19 |
| CH660126A5 (de) | 1987-03-31 |
| PT78313B (en) | 1986-06-02 |
| ES8601692A1 (es) | 1985-11-16 |
| GR81485B (enrdf_load_stackoverflow) | 1984-12-11 |
| ES539289A0 (es) | 1985-11-16 |
| GB8408067D0 (en) | 1984-05-10 |
| GB2137091B (en) | 1986-10-01 |
| KR840008284A (ko) | 1984-12-14 |
| KE3704A (en) | 1987-03-27 |
| SE8401748L (sv) | 1984-10-01 |
| AU2623684A (en) | 1984-10-04 |
| DE3311701A1 (de) | 1984-10-04 |
| CY1358A (en) | 1987-08-07 |
| PT78313A (en) | 1984-04-01 |
| FR2543435B1 (fr) | 1988-06-17 |
| ZA842337B (en) | 1984-11-28 |
| IT1173761B (it) | 1987-06-24 |
| ES530846A0 (es) | 1985-04-16 |
| GB2137091A (en) | 1984-10-03 |
| ES539290A0 (es) | 1985-11-16 |
| FR2543435A1 (fr) | 1984-10-05 |
| AU564956B2 (en) | 1987-09-03 |
| CA1212327A (en) | 1986-10-07 |
| PH20420A (en) | 1987-01-05 |
| LU85271A1 (de) | 1984-11-14 |
| ES8601693A1 (es) | 1985-11-16 |
| SE8401748D0 (sv) | 1984-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY100359A (en) | External pharmaceutical composition. | |
| JPS5312844A (en) | Nn44halogenobenzyllnnmethyl*or nonsubstitutedd*cycloalkylln**phenylurea or thiourea compounds* their preparation and fungicides containing the same as active constituents | |
| PT74703A (en) | Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine | |
| NZ192195A (en) | 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions | |
| IT1190824B (it) | Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo | |
| EP0173664A3 (en) | Biologically active benzimidazole compounds and process for their preparation | |
| NL7903400A (nl) | Werkwijze voor de bereiding van alpha,beta-onverzadigde n-gesubstitueerde carbonzuuramiden. | |
| DE2966411D1 (en) | Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions | |
| IL48238A (en) | N-(4-halobenzyl)-n-sec.alkyln'-phenylureas,their preparation and fungicidal compositions containing them | |
| NO941097L (no) | Hudregenererende kosmetisk preparat | |
| BE899277A (fr) | Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation. | |
| BE899278A (fr) | Agent antimycotique a haute liberation de substance active sous forme d'une creme. | |
| FR2453648A1 (fr) | Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique | |
| IT8521528A0 (it) | Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo. | |
| IT8320468A0 (it) | Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono. | |
| IT8121298A0 (it) | Nitroimidazoli ad attivita'tricomonacida, procedimento per laloro preparazione e relative composizioni farmaceutiche. | |
| SG13884G (en) | Compositions containing n-(2-amino-3,5-dibromobenzyl)-n-methyl-cycloh-exylamine and/or its salts | |
| IT8121960A0 (it) | Composti ad attivita' gaba simile, procedimento per prepararli e composizioni farmaceutiche cheli comprendono. | |
| IT8222873A0 (it) | Composti steroidei ad attivita'coleretica, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo. | |
| JPS53133207A (en) | Liquid shampoo composition | |
| HU175951B (en) | Herbicide compositions containing phenoxy-phenoxy-crotonoic acid, and process for producing the active agents | |
| IT8219456A0 (it) | Composto ad attivita'analgesica e antiinfiammatoria ad azione protratta, procedimento per la sua preparazione e relative composizioni farmaceutiche. | |
| FR2567756B1 (fr) | Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene | |
| IT8421627A1 (it) | Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo | |
| IT8219213A0 (it) | Composto ad attivita' mucoregolatri ce e antitosse,procedimento per lasua preparazione e relative composizioni farmaceutiche |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: *BAYER A.G. Effective date: 20040329 |